Review
Published on 31 Jan 2023
Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1099696
- 3,383 views
- 5 citations
Type at least 3 characters
1,334 articles
Articles
Original Research
Published on 31 Jan 2023
A novel prognostic model related to oxidative stress for treatment prediction in lung adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1078697
- 2,549 views
- 4 citations
Case Report
Published on 30 Jan 2023
Combined NK-CIK and PD-1 inhibitor (nivolumab), an effective immunotherapy for treating intrahepatic lymphoepithelioma-like cholangiocarcinoma unassociated with EBV infection: Two case reports and a literature review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1090580
- 1,675 views
- 4 citations
Case Report
Published on 27 Jan 2023
STK11 loss and SMARCB1 deficiency mutation in a dedifferentiated lung cancer patient present response to neo-adjuvant treatment with pembrolizumab and platinum doublet: A case report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1088534
- 1,995 views
- 2 citations
Original Research
Published on 27 Jan 2023
Tumor regression rate, PD-L1 expression, pembrolizumab/nab-paclitaxel–based regimens, squamous cell carcinoma, and comorbidities were independently associated with efficacy of neoadjuvant chemoimmunotherapy in non-small cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1057646
- 3,086 views
- 4 citations
Review
Published on 27 Jan 2023
Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1099811
- 12,442 views
- 50 citations
Original Research
Published on 26 Jan 2023
A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1087762
- 3,276 views
- 6 citations
Original Research
Published on 26 Jan 2023
SHP-2-induced M2 polarization of tumor associated macrophages via IL-4 regulate colorectal cancer progression
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1027575
- 2,609 views
- 5 citations
Review
Published on 25 Jan 2023
Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1011810
- 6,383 views
- 7 citations
Mini Review
Published on 24 Jan 2023
Targeting the cMET pathway to enhance immunotherapeutic approaches for mUM patients
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1068029
- 2,508 views
- 2 citations
Review
Published on 24 Jan 2023
Microenvironment and the progress of immunotherapy in clinical practice of NSCLC brain metastasis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1006284
- 2,799 views
- 2 citations
Original Research
Published on 23 Jan 2023
MMP11 is associated with the immune response and immune microenvironment in EGFR-mutant lung adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1055122
- 2,565 views
- 5 citations
Editorial
Published on 20 Jan 2023
Editorial: Imaging assessment of response to immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1116315
- 1,478 views
Original Research
Published on 19 Jan 2023
Enhancer RNA-based modeling of adverse events and objective responses of cancer immunotherapy reveals associated key enhancers and target genes
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1048127
- 2,470 views
Original Research
Published on 19 Jan 2023
Immunotherapy and tumor mutational burden in cancer patients with liver metastases: A meta and real word cohort analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.994276
- 1,937 views
- 2 citations
Review
Published on 18 Jan 2023
Role of B7 family members in glioma: Promising new targets for tumor immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1091383
- 3,808 views
- 3 citations